Oncotelic Therapeutics, Inc. (OTLC) Capital expenditures 2010–2016
Oncotelic Therapeutics, Inc. (OTLC) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$13,000FY2016 · since FY2010: $109,000 → $13,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2016 | $13,000 | -23.5% |
| FY2015 | $17,000 | — |
| FY2010 | $109,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice